March 30: PharmaTech Future Forward

PharmaTech is transforming how drugs are discovered, developed, regulated, and delivered. It’s the engine turning breakthrough science into scalable, data-driven innovation for patients. On March 30th in Tel Aviv, join industry thought-leaders and budget owners spanning Big Pharma and Venture Capital at "PharmaTech Future Forward", 10am-12pm, Naschitz Brandes & Amir law firm, 5 Tuval Street, Tel Aviv. Details Below:

Registration via LUMA: https://luma.com/zsvd6fuw
Date: Monday, March 30th
Time: 10am-12pm
Agenda:
Opening Remarks: Noga Spira, Naschitz, Brandes, Amir
MNC Perspectives: Lena Granovsky, Head of Israel R&D site / Senior Director, AI / ML, GSK Pharma
Ksenya Kveler, Principal Medical Science Manager, Health AI, Microsoft
Investors Roundtable: Roy Wiesner, Partner, aMoon; Gal Noyman Veksler, PhD, Partner, LionBird (US based); Yael Gruenbaum-Cohen, PhD, General Partner, Entree Bio
Pharma in Japan; Mihoko Horigome, mHealth Israel
Moderator: Ellie Hanson, FINN Partners

Join the leaders driving cross-disciplinary convergence and help define PharmaTech’s next chapter. Monday, March 30th, 5 Tuval Street, Tel Aviv. Link for registration is HERE; https://luma.com/zsvd6fuw